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Defective virusesIt is generally thought that pathogen-associated molecular patterns (PAMPs) responsible for triggering
interferon (IFN) induction are produced during virus replication and, to limit the activation of the IFN
response by these PAMPs, viruses encode antagonists of IFN induction. Here we have studied the induction of
IFN by parainﬂuenza virus type 5 (PIV5) at the single-cell level, using a cell line expressing GFP under the
control of the IFN-β promoter. We demonstrate that a recombinant PIV5 (termed PIV5-VΔC) that lacks a
functional V protein (the viral IFN antagonist) does not activate the IFN-β promoter in themajority of infected
cells. We conclude that viral PAMPs capable of activating the IFN induction cascade are not produced or
exposed during the normal replication cycle of PIV5, and suggest instead that defective viruses are primarily
responsible for inducing IFN during PIV5 infection in this system.nts. M.J.K., C.S.R., S.G. and R.E.R.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The interferon (IFN) response is an extremely powerful antiviral
defence mechanism that can control early phases of virus replication
within the host. To facilitate replication and spread, most (if not all)
viruses therefore employ mechanisms to at least partially circumvent
the IFN response (reviewed by Randall and Goodbourn, 2008).
Nevertheless, the ability of viruses to circumvent the IFN system is
not absolute and the IFN response remains critical in slowing the
progress of virus infections, thereby buying time for the development
of an adaptive immune response.
The current model of IFN induction holds that viruses generate
molecules (referred to as pathogen-associated molecular patterns, or
PAMPs) during their normal replication cycle that are not found in
uninfected cells. These PAMPs are speciﬁcally recognised by cellular
pathogen-recognition receptors (PRRs) that trigger downstream IFN
induction pathways (Takeuchi and Akira, 2009; Wilkins and Gale,
2010). RIG-I and MDA-5 are two such cytoplasmic PRRs; RIG-I
recognises short, 5′-triphosphorylated double-stranded RNA, whilst
MDA-5 recognises longer molecules of dsRNA which need not be 5′-triphosphorylated (Kato et al., 2008; Lu et al., 2010; Schlee et al., 2009;
Schmidt et al., 2009). Following binding of their appropriate ligands,
RIG-I and MDA-5 homo-oligomerise to reveal their CARD domains,
thereby facilitating their interaction with the CARDIF/MAVS/IPS1/
VISA adaptor protein. As a consequence of this interaction, the IFN
induction signal is transmitted to a number of downstream kinases,
including IKKα/β and TBK1/IKKε, resulting in activation of the
transcription factors NF-κB and IRF3, respectively. These transcription
factors, together with ATF-2/cJUN, are required for activation of the
IFN-β promoter, which ultimately results in the secretion of IFN-β
from infected cells. Secreted IFN binds to cell surface receptors and
activates intracellular signalling cascades to promote an antiviral state
by upregulating the expression of many interferon-stimulated genes
(ISGs) (Platanias, 2005; Randall and Goodbourn, 2008).
Viruses use a variety of strategies to limit IFN production. These
include encoding products that interfere with speciﬁc cellular
components of the IFN induction cascade, or which block cellular
transcription and/or protein synthesis (Haller et al., 2006; Randall and
Goodbourn, 2008). The paramyxovirus parainﬂuenza virus type 5
(PIV5) encodes the V protein, which is well characterised as an
IFN antagonist. V speciﬁcally binds to MDA-5, precluding it from
binding dsRNA and preventing its downstream signalling functions
(Andrejeva et al., 2004; Childs et al., 2007, 2009), and has also been
reported to act as a competitive inhibitor of TBK-1, the kinase that
phosphorylates and activates IRF3 (Lu et al., 2008). In addition to
inhibiting IFN induction, the V protein also acts to block IFN signalling
by targeting STAT1 for proteasome-mediated degradation (Didcock
et al., 1999; Precious et al., 2007). Thus, a recombinant virus, termed
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fragment, is extremely sensitive to the IFN system, being unable to
either block IFN signalling or limit IFN production (He et al., 2002;
Poole et al., 2002).
To follow activation of the IFN response in individual cells, we
recently generated a cell line, which reports faithfully the induction of
IFN-β at a single-cell level (Chen et al., 2010). Using this cell line, we
showed that there is heterocellular induction of IFN by negative strand
RNA viruses. This phenomenon has been observed several times
previously but was assumed to be a property of the host cell (Apostolou
and Thanos, 2008; Enoch et al., 1986; Hu et al., 2007; Senger et al., 2000;
Zawatzky et al., 1985). We demonstrated instead that, in our system, it
was a feature of the infecting virus as opposed to an intrinsic property of
the cells. Here we demonstrate that this heterocellular activation of the
IFN-β promoter also occurs for PIV5 lacking an IFN antagonist, as PIV5-
VΔC does not activate the IFN-β promoter in the majority of infected
cells. On the basis of our results, we propose that PAMPs that can
activate the IFN response are not produced or exposed during the
normal transcription and replication processes of PIV5.
Results
PIV5-VΔC induces GFP expression in A549/pr(IFN-β).GFP cells
We have previously generated and characterised a reporter cell
line, A549/pr(IFN-β).GFP, in which GFP is expressed under the control
of the IFN-β promoter (Chen et al., 2010). Here we have used these
cells to study the process of IFN induction by a recombinant PIV5 that
lacks a functional IFN antagonist (PIV5-VΔC). PIV5-VΔC encodes a C-
terminally truncated version of the V protein which cannot interact
with MDA-5 or target STAT1 for proteasome-mediated degradation
and is consequently impaired in its ability to inhibit IFN induction and
block IFN signalling in infected cells (He et al., 2002; Poole et al.,
2002). As expected, IFN was induced in A549/pr(IFN-β).GFP cells
infected with PIV5-VΔC, as indicated by an increase in IRF3
phosphorylation, IFN-α/β secretion and expression of GFP relative
to PIV5 wt-infected cells (Fig. 1). Furthermore, increased expression
of the ISG products ISG56 and MxA was observed in PIV5-VΔC-
infected cells, indicating that this virus was unable to block IFN
signalling. These data show, as has been shown previously, that
truncation of the PIV5 V protein leads to an increase in IFN production
in infected cells (He et al., 2002; Poole et al., 2002). This activation ofFig. 1. Activation of the IFN response by PIV5-VΔC in A549/pr(IFN-β).GFP reporter cells. A54
Uninfected (UI) cells were included as a negative control. Twenty-four hours post-infection,
immunoblotting with antibodies speciﬁc to phosphorylated (active) IRF3, GFP, ISG56, MxA
estimated by a CPE-reduction bio-assay and converted to IU IFN/106 cells using an IFN-α stan
and error bars represent the SD for each triplicate.the IFN-β promoter is accompanied by an increase in GFP expression
in our reporter cells, indicating that the A549/pr(IFN-β).GFP cell line is
valid for use in studying activation of the IFN response by PIV5-VΔC.
Heterogeneity in IFN-β promoter activity in PIV5-VΔC-infected cells
Since it is generally thought that PAMPs are produced during
normal virus replication and the V protein functions to block
activation of the IFN response by these replication products, we
reasoned that the detectable markers of IFN induction seen in the cell
population experiments described above (Fig. 1) would be reﬂected in
the activation of the IFN-β promoter by PIV5-VΔC in every infected
cell. Flow cytometry analysis of A549/pr(IFN-β).GFP cells infected
with wild-type PIV5 or with PIV5-VΔC was used to monitor GFP
expression in individual cells (Fig. 2A). As expected, and consistent
with PIV5 wt being a poor inducer of IFN expression, GFP was
detectable in only a small percentage (b2%) of cells infected with PIV5
wt at high multiplicity. However, surprisingly, in cells infected with
PIV5-VΔC, although there was an increase in the total number of GFP-
positive cells compared to wt virus infection, only a minority (10.7%)
of infected cells were positive for GFP; the majority of cells remained
GFP-negative. These results were conﬁrmed by immunoﬂuorescence,
which clearly showed that the majority of PIV5-VΔC-infected cells
were negative for GFP (Fig. 2B). The low numbers of GFP-positive cells
seen with these viruses were unlikely to be due to variation in the
ability of individual A549/pr(IFN-β).GFP cells to respond to IFN
inducers since ~75% of cells expressed GFP when infected with MuV
(ori), a stock of mumps virus known to be a good inducer of IFN due to
the presence of defective viruses (Fig. 2A; Chen et al., 2010). It is thus
clear from these data that in this system, the IFN-β promoter is active
in only a small subset of cells infected with PIV5-VΔC and it is likely
that these cells are responsible for the IFN secreted by PIV5-VΔC-
infected cell populations.
Heterogeneity in IFN-β promoter activity in developing plaques of
PIV5-VΔC
We next examined whether the heterocellular activation of the
IFN-β promoter seen in response to PIV5-VΔC infection is seen during
the development of virus plaques. PIV5-VΔC is extremely sensitive to
the effects of IFN, and so only forms small plaques in IFN-competent
A549/pr(IFN-β).GFP cells; nevertheless, plaque development can be9/pr(IFN-β).GFP cells were infected with PIV5 wt or PIV5-VΔC at an MOI of 5 PFU/cell.
culture media were harvested and cell lysates were prepared. Lysates were subjected to
, PIV5 V (C-terminus), actin and viral NP (left panel). IFN present in culture media was
dard. The mean IFN produced in three independent experiments is plotted (right panel)
Fig. 2. The IFN-β promoter is activated in only a subset of PIV5-VΔC-infected cells. (A) A549/pr(IFN-β).GFP cells were infected with PIV5 wt, PIV5-VΔC or MuV(ori) (as a positive
control) at 5 PFU/cell. Uninfected (UI) cells were included as a negative control. Sixteen hours post-infection, cells were trypsinised, ﬁxed and subjected to ﬂow cytometry analysis to
determine GFP expression. The percentage of cells considered to be GFP-positive (based on the line gate indicated) is given in the top right hand of each panel. (B) A549/pr(IFN-β).
GFP cells were infected with PIV5-VΔC at 10, 1 or 0.1 PFU/cell. Sixteen hours post-infection, cells were ﬁxed and immunostained for viral NP expression. GFP (green) and NP (red)
were visualised by ﬂuorescence microscopy. The presence of the nuclei (blue) in the merged images was visualised by DAPI staining.
41M.J. Killip et al. / Virology 415 (2011) 39–46followed at early times p.i., before enough IFN is produced to prevent
further plaque development. As seen for PIV5 wt (Fig. 3, middle
panels; Chen et al., 2010), the IFN-β promoter was only activated in a
minority of cells within developing PIV5-VΔC plaques at 2 days post-
infection (Fig. 2, right panels). As expected, the uninfected cells
surrounding plaques containing a GFP-positive cell were positive for
MxA expression, indicating activation of the IFN response. However,
plaques could also be seen that contained no GFP-positive cells,Fig. 3. Heterocellular activation of the IFN-β promoter in PIV5-VΔC developing plaques. A54
virus plaques. Two days post-infection, cells were ﬁxed, permeabilised and immunostained fo
response activation. Uninfected cells were treated with IFN-α as a positive control for Mx
microscopy.indicating that the IFN-β promoter had not been activated within
these developing plaques. Furthermore, an antiviral state had not
been established in the uninfected cells surrounding these plaques (as
demonstrated by a lack of MxA expression; Fig. 2, top right panel),
indicating that no endogenous IFN-β had been secreted by any of the
infected cells in the plaque. [It should be noted that as previously
observed for PIV5 wt (Chen et al., 2010), all plaques had at least one
GFP-positive cell in them by 3–4 days p.i. At this point, the further9/pr(IFN-β).GFP cells were infected with either PIV5 wt or PIV5-VΔC to obtain discrete
r viral NP and cellular MxA. MxA is upregulated by IFN and is therefore indicative of IFN
A expression. GFP (green), NP (red) and MxA (blue) were visualised by ﬂuorescence
Fig. 4. Generation of DI-rich preparations of PIV5-VΔC. (A) A549/pr(IFN-β).GFP cells were infected at 5 PFU/cell with PIV5-VΔC vM0 or vM2 stocks, or mock-infected, in the presence
of cycloheximide (50 μg/ml). Two hours later, monolayers were harvested and analysed for input virus NP and actin by SDS-PAGE and immunoblotting. (B) A549/pr(IFN-β).GFP cells
were infected at an MOI of 10 PFU/cell with PIV5 wt vM0, PIV5-VΔC vM2 or 50:50 mixtures of both of these viruses, or mock-infected. At 20 h p.i. the monolayers were radioactively
labelled with [35S]methionine and the labelled polypeptides in total cell extracts were visualised by SDS-PAGE analysis and autoradiography. The positions of the viral NP and M
proteins are highlighted with an *. (C) A549/pr(IFN-β).GFP cells were infected at an MOI of 10 PFU/cell with PIV5 wt vM0, PIV5-VΔC vM2 or 50:50 mixtures of both of these viruses.
At 20 h p.i. cells were ﬁxed and the distribution of NP was visualised by immunostaining and ﬂuorescence microscopy. (D) Total RNA was prepared from either mock-infected 293
cells or 293 cells infected at an equivalent PFU/cell with either PIV5-VΔC vM0 or PIV5-VΔC vM2, and then subjected to RT-PCR as described in Materials and methods. Reverse
transcription was performed with primer A or B, and then PCR was carried out with primer pairs B+C (vRNA primers) or A+C (copyback primers). Primers B and C are in opposing
orientations and permit ampliﬁcation of any PIV5 RNA generated by authentic replication. Primers A and C are both from the same strand and can only generate a PCR product if the
template has switched strands. Products were analysed on a 1.2% agarose gel and the presence of vRNA and copyback molecules is indicated. The faint DNA fragment seen in the
mock-infected sample with the copyback primers has a similar but distinct mobility to that seen with the copyback fragment and is non-speciﬁc.
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plaqueswhich continued to develop slowly due to the ability of the wt
virus to dismantle the IFN-induced antiviral state (Carlos et al., 2009;
Precious et al., 2007).] These results conﬁrm that the IFN-β promoter
is not activated in the majority of cells infected with PIV5-VΔC,
demonstrating that PAMPs capable of inducing IFN are not generated
during PIV5-VΔC transcription and replication processes.
Induction of IFN by PIV5-VΔC correlates with the presence of DI viruses
For other negative strand RNA viruses including Sendai virus,
mumps virus and VSV (Chen et al., 2010; Fuller and Marcus, 1980;
Johnston, 1981; Marcus and Gaccione, 1989; Sekellick and Marcus,
1989; Strahle et al., 2006), it has been shown that virus stocks that are
rich in defective interfering (DI) viruses are powerful activators of the
IFN response. Since our data clearly demonstrate that PAMPs capable of
activating the IFN response are not generated during normal PIV5-VΔCFig. 5. Induction of IFN by PIV5-VΔC correlates with the presence of DI viruses. (A) Equivalen
16 h post-infection and immunostained for NP expression. GFP (green) and NP (red) were v
and subjected to a CPE-reduction bio-assay to estimate the IFN present. Relative units of IFN
GFP and anti-NP panels, respectively. (B) A549/pr(IFN-β).GFP cells were infected with PIV
trypsinised, ﬁxed and subjected to ﬂow cytometry analysis to determine GFP expression. Th
given in the top right hand of each panel. (C) Lysates of A549/pr(IFN-β).GFP cells infected w
antibodies speciﬁc to phosphorylated IRF3 (p-IRF3), GFP, ISG56, MxA, viral NP and actin. Utranscription and replication, we sought to determine whether DI
viruses are primarily responsible for inducing IFN in PIV5-infected cells.
DI virus-rich stocks of PIV5-VΔC were generated by sequentially
passaging the virus at high multiplicity, a process known to increase
the number of DI viruses in the virus population. Sequential high MOI
passages are referred to as vM1, vM2, etc., after Von Magnus (1951)
who ﬁrst showed that highMOI passage of inﬂuenza virus leads to the
generation of DI viruses. The presence of DI viruses in our vM2 stock
could be demonstrated by examining the levels of input NP protein in
cells infected with the vM0 and vM2 viruses at equal multiplicity in
the presence of cycloheximide. Fig. 4A shows substantially more NP
present in vM2-infected cells than for vM0, indicating an increase in
the total number of input virus particles relative to the infectious titre.
In addition, the vM2 virus preparation inhibited the replication and
protein expression of PIV5 wt (Fig. 4B and C), a characteristic that has
been used previously to estimate the numbers of DIs in a virus stock
(Marcus et al., 2009).t dilutions of PIV5-VΔC were used to infect A549/pr(IFN-β).GFP cells. Cells were ﬁxed at
isualised by ﬂuorescence microscopy. Culture media were collected from infected cells
(RUI) produced and the MOI (PFU/cell) for each virus dilution are shown as insets in the
5-VΔC vM0 and vM2 preparations at 1–2 PFU/cell. At 16 h post-infection, cells were
e percentage of cells considered to be GFP positive (based on the line gate indicated) is
ith 5 PFU/cell of PIV5-VΔC vM0 or vM2 for 24 h were subjected to immunoblotting with
ninfected (UI) cells were included as a negative control.
43M.J. Killip et al. / Virology 415 (2011) 39–46In previous studies on the DI particles of paramyxoviruses it has
been shown that IFN induction is associated with the presence of
copyback genomes thought to be generated by template switchingduring replication (Strahle et al., 2006; Takaki et al., 2011). We
therefore investigated whether these copyback genomes could be
detected in our PIV5-VΔC stocks using RT-PCR on RNA extracted from
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Kolakofsky (Calain et al., 1992). In contrast to our ability to detect
vRNA at equivalent levels in RNA samples from cells infected by either
vM0 or vM2 stocks we observed a fragment ampliﬁed by the same-
sense copyback primer pair that, although present in the vM0 sample,
was more abundant in the vM2 sample (Fig. 4C). This fragment was
recovered and shown by DNA sequencing to be derived from a
template switching event in the RNA such that PIV5 nucleotide 14,043
is transposed next to nucleotide 15,023 in the opposite strand. This
event would generate a predicted copyback DI particle of 1428 nt in
length, with a perfect dsRNA stem of 223 bp, and this particle obeys
the rule-of-six.
The induction of IFN and GFP expression increased dramatically
when A549/pr(IFN-β).GFP cells were infected with this vM2 stock
compared to our original (vM0) stock of PIV5-VΔC (Fig. 5A). Thus,
following infection with PIV5-VΔC vM0 only a small proportion of
cells were GFP-positive, while in striking contrast, PIV5-VΔC vM2
resulted in the majority of cells expressing GFP. This increase in GFP
expression was consistent with a large increase in IFN secretion by
infected cells (Fig. 5A). Differences in GFP expression were quantiﬁed
by FACS analysis: following infection of the A549/pr(IFN-β).GFP cells
with 1–2 PFU/cell, ~12% of cells were positive for GFP following
infection with PIV5-VΔC vM0, while ~80% were positive following
infection with PIV5-VΔC vM2 (Fig. 5B). PIV5-VΔC vM2-infected cell
lysates also exhibited considerably more IRF3 phosphorylation than
PIV5-VΔC vM0-infected cells (Fig. 5C). Interestingly, there was no
difference in the level of MxA expression in the vM0- vs. vM2-infected
cells, presumably because all the PIV5-VΔC-infected cells would have
responded to any IFN produced due to the inability of PIV5-VΔC to
block IFN signalling. In contrast the level of ISG56 was higher in the
vM2-infected cells compared to the vM0-infected cells, because, in
addition to being upregulated by IFN, its expression is also directly
induced by activated IRF3 (Grandvaux et al., 2002). It is likely then
that the majority of ISG56 induced in the vM2-infected cells had been
induced by IRF3. It is also of note that the 10−3 dilution of vM2 virus
(0.02 pfu/cell) induced signiﬁcantly more IFN- and GFP-positive cells
than the 10−1 dilution of the vM0 virus (6 pfu/cell). This demon-
strates that the ability of the vM2 virus to induce IFN relative to vM0
was not due to either an increase in the amount of virus binding to the
cell or an increase in the number of input virus genomes. Plaque
puriﬁcation of PIV5-VΔC from the DI-rich vM2 stock reduced its
ability to induce IFN to that observed with our original non-defective
stock, showing that it was the accumulation of DI viruses that was
responsible for the increase in IFN induction, and not any selected
genetic changes in the properties of the non-defective virus that may
occur on high multiplicity passage (data not shown). Taken together,
our data indicate that normal replication of “non-defective” PIV5-VΔC
does not activate the IFN-β promoter even though it does not encode a
functional IFN antagonist. Rather, the induction of IFN by PIV5-VΔC in
this system is primarily due to the presence of DI viruses.
Discussion
A great deal of work has been done previously on the induction of
IFN by paramyxoviruses and the role of their IFN antagonists in
blocking activation of IFN induction pathways. Since these studies
have focused on data obtained from cell population experiments, they
failed to analyse the process of IFN induction in individual cells. We
have previously examined the induction of IFN at the single-cell level
(using our A549/pr(IFN-β).GFP cells) during infection with a range of
wild-type negative-sense viruses, and observed heterocellular IFN-β
promoter activity caused by differences in the infecting virus
population (Chen et al., 2010). One possible explanation for this
heterogeneity is that a virus infecting a cell that will go on to express
GFP has been unable to block IFN induction by PAMPs that are
generated during normal virus transcription or replication, either dueto defective function or a loss of expression of the IFN antagonist. If the
loss of a functional V protein were the primary reason for IFN
induction in infected cells, then it would be expected that PIV5-VΔC
would activate the IFN-β promoter in all infected cells. However, we
found instead that only a small minority of A549/pr(IFN-β).GFP
reporter cells expressed GFP when infected with our working stock of
PIV5-VΔC. This was not due to differences in the ability of individual
cells to respond to IFN inducers since the majority of cells expressed
GFP when infected with a preparation of MuV known to be a good IFN
inducer due to the presence of DI viruses. Similarly, by sequential high
multiplicity passage of PIV5-VΔC to increase the number of DI viruses
present, we could generate a PIV5-VΔC stock that activated GFP
expression (and therefore the IFN-β promoter) in 80% of cells,
consistent with previous studies indicating a correlation between
paramyxovirus DI viruses and IFN induction (Johnston, 1981; Strahle
et al., 2006). Moreover, the increase in GFP expression seen with our
DI-rich PIV5-VΔC correlatedwith an increase in IRF3 phosphorylation,
ISG expression and IFN secretion by infected cells, suggesting that our
GFP reporter system faithfully represents the activation of the IFN
response in infected cells. We also observed that the IFN-β promoter
was only activated in a minority of cells within developing PIV5-VΔC
plaques, and furthermore, plaques could be found in which no cells
expressed GFP at all. Since the uninfected cells surrounding these
GFP-negative plaques were also negative for the ISG product MxA,
clearly no endogenous IFN-β had been secreted by any of the cells
within these plaques, further indicating a close correlation between
the activity of our reporter gene and the activity of the endogenous
IFN-β gene.
The most striking result of this study was that the loss of the PIV5
IFN antagonist did not lead to IFN-β promoter activation in all PIV5-
VΔC-infected cells. We considered the possibility that PIV5 may
encode an uncharacterised trans-acting inhibitor of IFN-β induction
that remains intact in the PIV5-VΔC genome and hence could limit the
number of cells expressing GFP. However, in related studies we have
found that whilst infection of cells with PIV5 wt blocks their ability to
activate the IFN-β promoter in response to a variety of PAMPs,
infection with PIV5-VΔC vM0 does not (data not shown). The data
presented here challenge the notion that paramyxoviruses generate
PAMPs capable of activating the IFN response during their normal
replication cycle, and we suggest that these PAMPs are not generated
during non-defective PIV5 transcription and replication. It is of note
that the replication of negative strand RNA viruses is strictly linked to
encapsidation of virus genomes and antigenomes (Gubbay et al.,
2001), thereby hiding any potential structures in the genomes/
antigenomes that could be recognised by RIG-I/MDA-5 (Goodbourn
and Randall, 2009). Furthermore, it has been reported that PIV5
strictly regulates its transcription and replication processes in order to
limit the production of aberrant RNAs that may otherwise activate the
IFN response (Dillon and Parks, 2007; Gainey et al., 2008; Lin et al.,
2005; Manuse and Parks, 2009). In addition to its role as an IFN
antagonist, the V protein itself controls both PIV5 transcription and
replication (Lin et al., 2005). In this regard it may be expected that due
to the extensive deletion in V in PIV5-VΔC this V-dependent
regulation would be altered, leading to a possible increase in the
generation of PAMPs capable of inducing IFN. However, our data
indicate that the loss of this ﬁne control of transcription and
replication does not affect the level of IFN induction during infection,
since we do not see IFN-β promoter activation in the majority of PIV5-
VΔC-infected cells.
Since we have shown that non-defective PIV5-VΔC does not
generate PAMPs capable of activating the IFN-β promoter during its
normal replication cycle, we suggest that, in this reporter system, DI
viruses (which must be generated frequently during PIV5 replication,
given the ease with which we were able to generate DI virus-rich
stocks) are primarily responsible for IFN induction by PIV5. These
results also raise the question of the role of V in blocking IFN induction
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One possibility is that V blocks IFN induction by PAMPs that are
generated by DIs, either within cells in which the DI was initially
generated, or in cells that have been co-infected with a wt virus and
an IFN-inducing DI. Alternatively, infection of certain cells (e.g.,
plasmacytoid dendritic cells) may result in defective or altered virus
replication and the generation of PAMPs capable of activating the IFN
response, and it is the function of V to block IFN induction within
these cells.
Materials and methods
Cells, viruses and IFN
Vero, A549 and 293 cells, and their derivatives, were grown as
monolayers in Dulbecco's modiﬁed Eagle's medium (DMEM) supple-
mented with 10% foetal bovine serum at 37 °C. PIV5 (strain W3A;
Choppin, 1964), PIV5-VΔC (He et al., 2002) and MuV(ori) (Enders;
Chen et al., 2010) were grown and titrated under appropriate
conditions in Vero cells or, where stated, in A549 cells. Virus infections
were carried out in DMEM supplemented with 2% foetal bovine
serum. The construction and properties of the A549/pr(IFN-β).GFP
cell line have been previously and extensively described (Chen et al.,
2010). IFN-α (Roferon A; Roche) was used at 1000 IU/ml.
Generation of DI-rich virus preparations
To generate DI virus-rich stocks of PIV5-VΔC, Vero cells grown in
75 cm2 ﬂasks were infected at an MOI of 5 PFU/cell with our working
stocks (vM0). Every 2 – 3 days the culture medium was harvested;
half was frozen at −70 °C for subsequent analysis and the other half
used to infect the next 75 cm2 ﬂask. Sequential preparations of these
stocks are referred to as vM1, vM2, etc.
Analysis of copyback RNA in DI-rich virus preparations
Total cellular RNAwas prepared from 293 cells infected with PIV5-
VΔC vM0 or vM2 stocks, prepared as described above, at an MOI of 5
PFU/cell. Two micrograms of total cellular RNA was reverse
transcribed with RevertAID reverse transcriptase (Fermentas) using
oligos A (5′-CCAAGAAGACCTAAATTGTAAGGAG-3′) or B (5′-CTCCTTA-
CAATTTAGGTCTTCTTGG-3′) which are complementary to the (+) and
(−) strand, respectively, for nucleotides 14760–14784. cDNA was
subsequently ampliﬁed with AccuPrime Pfx DNA polymerase (Invi-
trogen) using either oligo A paired with oligo C (5′-GGATTGGATCC-
GAATGCTGCCAAGGGGAAAACCAAGATTAATCCTCT-3′) or oligo B
paired with oligo C (oligo C is complementary to nucleotides
15218–15246, the terminus of the PIV5 genome). Ampliﬁcation
products were separated by agarose gel electrophoresis, recovered
and cloned as blunt-ended fragments into pJET1.2 (Fermentas) and
sequenced (GATC Biotech).
Immunoﬂuorescence, immunoblotting and FACS analysis
The procedures for immunoblotting and immunoﬂuorescence
have previously been described (Carlos et al., 2005). Antibodies
used in these procedures included monoclonal antibodies against
PIV5 NP (PIV5-NPa; Randall et al., 1987), PIV5 V (raised against the
C-terminus; a kind gift from R. Lamb), phospho-IRF3 (Cell Signaling
Technology), GFP (Roche), and β-actin (Sigma). Polyclonal antibodies
used included those raised against ISG56 (Santa Cruz) andMxA (Santa
Cruz). Immunoﬂuorescence was examined with either a Nikon
Microphot-FXA immunoﬂuorescence microscope or a Zeiss LSM 5
Exciter confocal microscope. For FACS analysis, A549/pr(IFN-β).GFP
cells were trypsinised to obtain single-cell suspension and ﬁxed inPBS/5% formaldehyde. GFP expression was examined using a BD
FACScan ﬂow cytometer.
Interferon assays
The amount of IFN secreted by cells was determined by a CPE-
reduction bio-assay. Brieﬂy, culture supernatants from infected cells
were harvested, centrifuged at 1500×g for 10 min to pellet cellular
debris, UV-treated to inactivate residual virus, then serially diluted 2-
fold and added to A549/BVDV-Npro cell monolayers (Hilton et al.,
2006) for 18 h prior to infection with EMCV (0.05 PFU/cell). Mono-
layers were ﬁxed 2–3 days post-infection (with PBS/5% formalde-
hyde) and cytopathic effect (CPE) was monitored by staining with
0.1% crystal violet.
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